33.700
+0,60%
2026-10-15
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -31.0% | +0.2% | 2 / 3 | -24.7% | -0.67 pp | -5.12 pp | +21.4% | 0.04 | 8.60 | 25,3 | −24,7% | 14,2 | −31,0% | 8.60 | 7.87 | +9,2% |
| Pts | 0 | 0 | 8 | 0 | 4 | 0 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 33.700 (close price on 2026-10-15)EPS (TTM): 3.920
Financial charts
1.Revenue & growth
VND bn25,3Q2/26
1.Revenue & growth
VND bn25,3Q2/26
2.Profit & growth
VND bn13,0Q2/26
3.Profit mix (Penman)
VND bn89,7Q2/26
4.Margins & cost structure
%63.0%Q2/26
5.Returns & cash cycle
% · days21.0%Q2/26
6.Earnings quality & cash
VND bn72,1Q2/26
7.Asset structure
VND bn380Q2/26
8.Funding & debt health
VND bn · times380Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %8,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %700Q2/26
Adjusted EPS growth, latest quarter
-36.9%
Average adjusted EPS growth, 3 quarters
-1.8%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26